Bill > SB132

This bill modifies Alabama's controlled substances law by adding psychoactive derivatives of hemp to Schedule I drugs, which are substances considered to have a high potential for abuse and no accepted medical use. The bill expands the existing list of controlled substances to include numerous synthetic cannabinoids, cathinones, tryptamines, and other chemical compounds with psychoactive effects. Specifically, it adds language that classifies psychoactive cannabinoids derived from hemp as controlled substances, removing a previous exemption for non-psychoactive cannabinoids. The bill also repeals a section of law that prohibited selling psychoactive cannabinoids to minors and sets an effective date of October 1, 2025. The extensive list of newly scheduled substances includes numerous chemical compounds with complex names that are often found in synthetic drugs designed to mimic the effects of traditional controlled substances. By broadly defining synthetic controlled substance analogues and their chemical structures, the bill aims to proactively control new psychoactive substances that might be developed to circumvent existing drug laws.

Health and Social Services

https://alison.legislature.state.al.us/bill-search